Clinical Trial Update: A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating MK-686 for osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• MK-686

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED